Clinical Trials
2 trialsNCT06824467 2026-05-08
TroFuse-022
Merck Sharp & Dohme LLC
Phase 3 Recruiting
NCT01846611 2019-04-01
A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Janssen Research & Development, LLC
Phase 3 Completed